Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Sep 15, 2025; 17(9): 107651
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.107651
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.107651
Table 1 Comparison of general data among different groups, n (%)
UA, mg/dL | Q1 (0.67-4.40) | Q2 (4.41-5.41) | Q3 (5.42-6.29) | Q4 (6.30-15.14) | P value |
Age, years | < 0.001 | ||||
< 60 | 1040 (52.13) | 1177 (58.12) | 1295 (63.67) | 1361 (67.18) | |
≥ 60 | 955 (47.87) | 848 (41.88) | 739 (36.33) | 665 (32.82) | |
Gender | < 0.001 | ||||
Male | 597 (29.92) | 961 (47.46) | 1211 (59.54) | 1729 (85.34) | |
Female | 1398 (70.08) | 1064 (52.54) | 823 (40.46) | 297 (14.66) | |
BMI, kg/m2 | < 0.001 | ||||
< 18.5 | 86 (4.31) | 27 (1.33) | 16 (0.79) | 7 (0.35) | |
18.5-24.9 | 1501 (75.24) | 1349 (66.62) | 1339 (65.83) | 1041 (51.38) | |
25.0-29.9 | 362 (18.15) | 557 (27.51) | 547 (26.89) | 765 (37.76) | |
≥ 30.0 | 46 (2.31) | 92 (4.54) | 132 (6.49) | 213 (10.51) | |
Smoking history | < 0.001 | ||||
Yes | 1768 (88.62) | 1702 (84.05) | 1730 (85.05) | 1581 (78.04) | |
No | 227 (11.38) | 323 (15.95) | 304 (14.95) | 445 (21.96) | |
Drinking history | < 0.001 | ||||
Yes | 1808 (90.63) | 1703 (84.10) | 1698 (83.48) | 1459 (72.01) | |
No | 187 (9.37) | 322 (15.90) | 336 (16.52) | 567 (27.99) | |
Family history | 0.019 | ||||
Yes | 1957 (98.10) | 1983 (97.93) | 2007 (98.67) | 2006 (99.01) | |
No | 38 (1.90) | 42 (2.07) | 27 (1.33) | 20 (0.99) | |
Diabetes | < 0.001 | ||||
Yes | 1802 (90.33) | 1893 (93.48) | 1915 (94.15) | 1876 (92.60) | |
No | 193 (9.67) | 132 (6.52) | 119 (5.85) | 150 (7.40) | |
Hypertension | < 0.001 | ||||
Yes | 1736 (87.02) | 1701 (84.00) | 1771 (87.07) | 1619 (79.91) | |
No | 259 (12.98) | 324 (16.00) | 263 (12.93) | 407 (20.09) | |
LDL-C, mmol/L | 2.49 ± 0.67 | 2.58 ± 0.68 | 2.59 ± 0.70 | 2.61 ± 0.67 | < 0.001 |
HDL-C, mmol/L | 1.37 ± 0.42 | 1.29 ± 0.32 | 1.24 ± 0.30 | 1.15 ± 0.26 | < 0.001 |
Table 2 Uric acid and colon cancer risk in different models
Table 3 Threshold effect analysis in different gender groups
UA, mg/dL | Total (n = 8080) | Males (n = 4498) | Females (n = 3582) | |||
OR (95%CI) | P value | OR (95%CI) | P value | OR (95%CI) | P value | |
Turingpoint | 4.79 | 4.69 | 4.83 | |||
< Turingpoint | 0.43 (0.37-0.49) | < 0.001 | 0.34 (0.26-0.44) | < 0.001 | 0.39 (0.33-0.47) | < 0.001 |
> Turingpoint | 0.78 (0.72-0.84) | < 0.001 | 0.73 (0.67-0.80) | < 0.001 | 1.01 (0.88-1.15) | 0.9362 |
P value | < 0.001 | < 0.001 | < 0.001 |
- Citation: Sun TF, Fan KX, Luo YX, Song J, Han ZX, Zhang XL. Relationship between uric acid and colon cancer risk: Dose-response analysis and mechanisms. World J Gastrointest Oncol 2025; 17(9): 107651
- URL: https://www.wjgnet.com/1948-5204/full/v17/i9/107651.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i9.107651